MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 70 filers reported holding MONTE ROSA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $22,542 | +2.4% | 2,893,717 | 0.0% | 1.48% | +0.7% |
| Q4 2022 | $22,021 | -99.9% | 2,893,717 | -3.3% | 1.47% | -13.8% |
| Q3 2022 | $24,459,000 | -15.5% | 2,993,717 | 0.0% | 1.71% | -21.9% |
| Q2 2022 | $28,949,000 | -31.2% | 2,993,717 | -0.3% | 2.19% | -32.3% |
| Q1 2022 | $42,091,000 | -31.3% | 3,002,199 | 0.0% | 3.23% | -11.4% |
| Q4 2021 | $61,305,000 | -9.8% | 3,002,199 | -3.2% | 3.65% | +32.1% |
| Q3 2021 | $67,957,000 | -2.3% | 3,102,199 | -2.9% | 2.76% | +16.8% |
| Q2 2021 | $69,550,000 | – | 3,193,973 | – | 2.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $7,052,465 | 2.91% |
| NEA Management Company, LLC | 7,692,298 | $36,846,107 | 2.85% |
| Octagon Capital Advisors LP | 812,895 | $3,893,767 | 0.60% |
| Alphabet Inc. | 1,464,015 | $7,012,631 | 0.45% |
| Avoro Capital Advisors LLC | 4,535,000 | $21,722,650 | 0.34% |
| Casdin Capital, LLC | 510,882 | $2,447,125 | 0.27% |
| Baker Brothers Advisors | 4,916,095 | $23,548,095 | 0.14% |
| Corton Capital Inc. | 14,460 | $69,263 | 0.04% |
| ExodusPoint Capital Management, LP | 619,248 | $2,966 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 27,844 | $133,373 | 0.02% |